Aurobindo Pharma’s subsidiary, Eugia Pharma, has launched Pomalidomide Capsules in the U.S., targeting the $3.3?billion oncology and specialty drug market.
A new study shows laser treatment before immunotherapy could help patients with aggressive brain tumors live longer.
Glenmark plans to launch affordable semaglutide in India, competing with major players like Sun Pharma and Dr. Reddy’s. Aiming to revolutionize the anti-diabetes market.
U.S. drugmaker Eli Lilly will continue selling its innovator diabetes and obesity drug at premium prices in India even as the market prepares for the arrival of lower-priced generic drugs. The company says it is not planning price reduction...
.jpeg "NATCO Pharma Introduces Generic Blood Cancer Drug in US Market")
NATCO Pharma launches generic Pomalidomide capsules in the US for blood and bone marrow cancer, strengthening its oncology portfolio and improving patient access to treatment.
The Medicity has launched a public awareness campaign to shift the focus from seasonal concern over air pollution to continuous monitoring and prevention of chronic respiratory diseases (CRDs).
Sai Life Sciences is gaining momentum as India’s pharma boom drives demand for drug development and manufacturing services, posting strong revenue and profit growth in 2026.
.jpeg "MedGenome Invests in Medcare Diagnostics to Expand in Western India")
MedGenome invests in Medcare to strengthen India’s integrated diagnostics ecosystem, combining advanced imaging, pathology, and genomics for better early disease detection.
The ongoing Gulf conflict is disrupting India’s medical tourism and pharma exports, causing flight cancellations, rising shipping costs, and delays that threaten revenue for hospitals and drug manufacturers.
.png "Pharma PLI Scheme Reopens to Boost Bulk Drugs in India Drive")
India has reopened the Pharma PLI scheme for select bulk drugs, giving manufacturers another chance to secure incentives and scale up domestic API production.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")